Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy in Vietnam
Recruiting
N/A
Interventional Study
Hypoxic-ischemic Encephalopathy (HIE)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 0 Hours – 6 Hours
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 120 (estimated)
- Sponsor
- National Children's Hospital, Vietnam · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to evaluate the effectiveness of therapeutic hypothermia in neonates diagnosed with hypoxic-ischemic encephalopathy (HIE). The study focuses on assessing both short-term outcomes after treatment and long-term neurological outcomes following therapeutic hypothermia.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Neonates diagnosed with hypoxic-ischemic encephalopathy (HIE) at the Neonatal Center, National Children's Hospital
* Gestational age ≥ 36 weeks
* Assessed using the modified Sarnat staging within the first 0-6 hours after birth
* Eligible for and/or treated with therapeutic hy…
Contacts